Japanese Regulators Increase Use of “Conditional Approvals” on Drugs
Amid discontent over Japan delay-ridden drug approval process, its regulatory authorities are making greater use of an instrument known as conditional approval. According to the Pharmaceutical Affairs Law, the Ministry of Health, Labor and Welfare (MHLW) can require the marketing authorization holder... Read More